New York, NY - Point Roberts, WA - March 26, 2014 (Investorideas.com Newswire) Investorideas.com, a global news source for leading sectors including biotech and pharma issues a sector snapshot of TSX biotech stocks targeting ovarian cancer as part of their product pipeline. Stocks mentioned include Quest PharmaTech Inc. (TSX.V: QPT), Oncolytics (TSX:ONC; NASDAQ:ONCY) , Immunovaccine, Inc. (TSX.V:IMV) and Aeterna Zentaris Inc. (AEZS) (TSX: AEZ).
MONTREAL, QC - May 12, 2014 (Investorideas.com Biotech Newswire) Sunshine Biopharma, Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer today announced that a “Notice of Allowance” for the patent application covering its lead antitumor compound, Adva-27a, has recently been issued in Canada. The allowed claims in Canada are nearly identical to those already issued in the United States where ... Read more
Albany, New York, August 17, 2017: Mesothelioma is one of the least common types of cancer and its incidence rates still hover around 3000 new cases each in the U.S., according to the latest report from Centers for Disease Control and Prevention. However, scientific research and increased awareness are leading to earlier diagnoses, while improved and developing mesothelioma treatments are allowing patients to live longer than ever. To elaborate further, a pipeline study ... Read more
